ImmunoGen, Inc. – Strategy, SWOT and Corporate Finance Report

ImmunoGen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Key Highlights

ImmunoGen, Inc. (ImmunoGen or ”˜the company’) is a developer of targeted anticancer therapeutics using its antibody-drug conjugate (ADC) technology. The ADC technology is comprised of the company's portfolio of cancer-cell killing agents that can be attached to antibodies for targeted delivery to cancer cells. ImmunoGen is headquartered in Waltham, Massachusetts, and employed 317 people as of June 30, 2015.

Scope

– Detailed information on ImmunoGen, Inc. required for business and competitor intelligence needs

– A study of the major internal and external factors affecting ImmunoGen, Inc. in the form of a SWOT analysis

– An in-depth view of the business model of ImmunoGen, Inc. including a breakdown and examination of key business segments

– Intelligence on ImmunoGen, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

– News about ImmunoGen, Inc., such as business expansion, restructuring, and contract wins

– Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of ImmunoGen, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess ImmunoGen, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on ImmunoGen, Inc.'s business structure, strategy and prospects.

Table of Contents

Table of Contents

Company Snapshot

ImmunoGen, Inc.: Company Overview

ImmunoGen, Inc.: Overview and Key Facts

ImmunoGen, Inc.: Overview

ImmunoGen, Inc.: Key Facts

ImmunoGen, Inc.: Key Employees

ImmunoGen, Inc.: Key Employee Biographies

ImmunoGen, Inc.: Major Products and Services

ImmunoGen, Inc.: Company History

ImmunoGen, Inc.: Management Statement

ImmunoGen, Inc.: Locations and Subsidiaries

ImmunoGen, Inc.: Key Competitors

ImmunoGen, Inc.: Company Analysis

ImmunoGen, Inc.: Business Description

ImmunoGen, Inc.: SWOT Analysis

ImmunoGen, Inc.: SWOT Overview

ImmunoGen, Inc.: Strengths

ImmunoGen, Inc.: Weaknesses

ImmunoGen, Inc.: Opportunities

ImmunoGen, Inc.: Threats

ImmunoGen, Inc.: Corporate Financial Deals Activity

ImmunoGen, Inc.: Financial Deals Overview

ImmunoGen, Inc.: Targets and Partners

ImmunoGen, Inc.: Top Deals 2014 - 2018YTD*

ImmunoGen, Inc.: Capital Raising

ImmunoGen, Inc.: Partnership

ImmunoGen, Inc.: Recent Developments

ImmunoGen, Inc.: News and Events Summary

ImmunoGen, Inc.: Corporate Governance

ImmunoGen, Inc.: Financial Performance

ImmunoGen, Inc.: Market Developments

ImmunoGen, Inc.: Red Flags/DistressSignals

ImmunoGen, Inc.: Research & Development

Appendix

Contact Us

Methodology

Definitions

About MarketLine

List of Tables

List of Tables

Table 1: ImmunoGen, Inc.: Key Facts

Table 2: ImmunoGen, Inc.: Key Employees

Table 3: ImmunoGen, Inc.: Locations and Subsidiaries

Table 4: ImmunoGen, Inc.: Key Competitors

Table 5: ImmunoGen, Inc.: Deal Activity by Deal Type – Volume (2014 – YTD*2018)

Table 6: ImmunoGen, Inc.: Targets and Partners

Table 7: ImmunoGen, Inc.: Top Deals 2014 – 2018YTD*

Table 8: ImmunoGen, Inc.: Capital Raising Volume and Value Trend (2014 – YTD*2018)

Table 9: ImmunoGen, Inc.: Capital Raising by Deal Type (2014 – YTD*2018)

Table 10: ImmunoGen, Inc.: Partnership Volume and Value Trend (2014 – YTD*2018)

Table 11: ImmunoGen, Inc.: Partnership Trend by Deal Type (2014 – YTD*2018)

Table 12: ImmunoGen, Inc.: News and Events Summary

Table 13: ImmunoGen, Inc.: Corporate Governance

Table 14: ImmunoGen, Inc.: Financial Performance

Table 15: ImmunoGen, Inc.: Market Developments

Table 16: ImmunoGen, Inc.: Red Flags/DistressSignals

Table 17: ImmunoGen, Inc.: Research & Development

List of Figures

List of Figures

Figure 1: ImmunoGen, Inc.: Deal Activity by Deal Type – Volume (2014 – YTD*2018)

Figure 2: ImmunoGen, Inc.: Capital Raising Volume and Value Trend (2014 – YTD*2018)

Figure 3: ImmunoGen, Inc.: Capital Raising by Deal Type (2014 – YTD*2018)

Figure 4: ImmunoGen, Inc.: Partnership Volume and Value Trend (2014 – YTD*2018)

Figure 5: ImmunoGen, Inc.: Partnership Trend by Deal Type (2014 – YTD*2018)

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports